SIME Diagnostics
Henrik Verder serves as a Professor of Neonatology & Pediatrics at Region Sjælland since January 1980, contributing extensive expertise in the field of neonatal care. Additionally, since January 2012, Henrik Verder holds the position of Chairman of the Clinical Advisory Board at SIME, a Clinical AI company dedicated to advancing medical diagnostics for respiratory intensive care. Under Henrik Verder's leadership, SIME focuses on leveraging proprietary AI and data solutions to enhance early intervention in critical illnesses, ultimately improving patient outcomes and reducing healthcare costs.
This person is not in any teams
This person is not in any offices
SIME Diagnostics
SIME is a clinical AI platform company committed to preventative, personalized point-of-care medicine. Their solutions provide data-driven and precise insights to doctors in decisive moments, when rapid intervention can save a life. Developed by world-renowned scientists and doctors, their data engine detects disease in real-time, enabling earlytreatment in high-risk patients. The first urgent unmet needs that we are addressing are in the neonatal intensive care unit; where our clinically proven, and patented technologies will have the greatest impact. Through curation and analysis, their AI platform generates unique datasets which can be used by SIME to discover new products, or by third-party commercial partners in all areas of medicine. SIME is a London (UK), Copenhagen (Denmark), and Shanghai (China) based company with over three decades of experience of pioneering innovation in medicine and data science.